I guess investors want to hear the cash register ring, and not...

I guess investors want to hear the cash register ring, and not focus on the big picture.

Vidcare is a small biotech company that has won a lot of innovation awards around the world.

Clearly, David is flagging that Vidcare has access to Government funding which is substantial enough to make this announcement.to the ASX.

Regards of this deal lets look at the overall market.

"The global market for conjugation and labeling services, which includes EDC/SNHS bioconjugation, is projected to grow significantly. It is estimated to increase from USD 0.9 billion in 2023 to USD 2.9 billion by 2035, with a compound annual growth rate (CAGR) of 10.2% during this period1.This growth is driven by the rising demand for conjugated biomolecules in research and development, particularly in the pharmaceutical sector."